Introduction
============

Endoscopic sinus surgery (ESS) is considered a selective treatment method and is widely performed in chronic sinusitis patients who do not respond to drug treatment. ESS can be performed under local anesthesia, but in most cases, it is performed under general anesthesia.

Intra-nasal bleeding during ESS surgery under general anesthesia makes the visible surgical field difficult; therefore bleeding can lengthen the time of the surgery and increase complications. Methods to reduce intra-nasal bleeding, such as keeping the head elevated during surgery to reduce intra nasal bleeding, nasal wall epinephrine administration \[[@B1]\], bradycardia that is induced during surgery \[[@B2]\], and inducing low blood pressure through fast-acting β-blocker or magnesium administration during surgery \[[@B3]\] or α-agonist administration before surgery \[[@B4],[@B5]\]. There is also the method of reducing intra nasal bleeding to obtain a visible surgical field through the selection of anesthesia.

In a direct comparison study of intravenous anesthesia such as propofol and inhalation anesthesia such as isoflurane and sevoflurane, intravenous anesthesia caused less intra nasal bleeding \[[@B6]-[@B8]\]. In another study that used the Lund-Mackay (LM) score from computed tomography (CT) findings to compare the extent of sinusitis and anesthesia in a severe sinusitis patient group, less bleeding and a better visible surgical field was noted in the group that received intravenous anesthetic with propfol than the group that received sevoflurane inhalation anesthesia \[[@B9]\].

This study attempted to compare the surgical field scores, according to the extent of the preoperative surgical lesions, for a group that used propofol/remifentanil (PR), reported to reduce the amount of bleeding to obtain a visible surgical field to a group that used sevoflurane/remifentanil, and to a group that used desflurane/remifentanil (DR).

Materials and Methods
=====================

Sixty-eight patients with the American Society of Anesthesiologists physical status class I or II diagnosed with chronic sinusitis and scheduled to receive endoscopic sinus surgery were chosen as subjects. Ahn et al. \[[@B9]\] noted that a numeric rating scale (NRS) was 4.8 on average and the standard deviation 2.4 when sevoflurane was utilized. In case of desflurane, a NRS was 2.9 on average, and standard deviation 1.6. We expected a conclusion similar to these, it was estimated that 32 subjects were needed to give this study a statistical power of 80% show a clinically relevant, a significance level of 0.05. As we expected 10% dropouts, we included 36 subjects in the each group. In this period, we had 32 patients in the DR group, 36 patients in the PR group. So, we performed a statistical analysis with these patients. This study attained approval from the clinical ethics board of the hospital. The patients were visited before anesthesia was given and the purpose of the study and possible complications were explained the written consent was obtained. The 68 patients were randomly assigned to two groups, PR (n = 36) and DR (n = 32). Patients taking antiplatelet agents or anticoagulants, patients with other bleeding tendencies, patients with asthma or fungal sinusitis, and patients undergoing surgery again were excluded from the study. To investigate the extent of the preoperative surgical lesion, the Lund-Mackay CT score was calculated \[[@B10]\] ([Table 1](#T1){ref-type="table"}), and a score \> 12 was categorized as a high-LM score and ≤ 12 as a low-LM score.

There were no medications before anesthesia, and basic noninvasive monitoring of arterial pressure, electrocardiogram, and pulse oximetry were initiated upon arrival into the operating room. The blood pressure was checked every 3 minutes. Anesthesia was induced with lidocaine 0.5 mg/kg, propofol 2 mg/kg, and rocuronium 0.6 mg/kg for both groups. Two L/min of air-O~2~ was used to administer 0.5 FiO~2~. Desflurane was administered at a 6-9 vol% for the DR group. For the PR group, propofol was continually injected using target a concentration infusion (TCI, Orchestra® Base Primea, Fresenius kabi, Germany) where the target blood concentration was set as 2-6 µg/ml. Both groups were equally intravenous injected with remifentanil 0.2 µg/min/kg during anesthesia induction, and after inducing anesthesia, it was continually injected at a maintenance dose of 0.15 µg/min/kg.

The target blood pressure was maintained at a mean arterial pressure of 70-80 mmHg, and was first controlled with a desflurane or propofol concentration. When blood pressure was not controlled with these two drugs, the concentration of remifentanil was controlled within 0.06-0.2 µg/min/kg to maintain the target blood pressure. End-tidal CO~2~ concentration was 35-40 mmHg, and a reverse Trendelenburg position of 20° was maintained. An infusion pump with a syringe filled with propofol was also mounted for the subjects in the DR group so a single blind experiment was conducted and the operating surgeon was blinded to the type of anesthesia that was used.

For all surgeries, a surgeon injected mixed solution of epinephrine and lidocaine 0.3 cc (1 : 100,000 epinephrine: lidocaine 2% at 1 : 1) at the both origin of middle turbinates. For all surgeries, in 10 minutes intervals, the same operating surgeon measured the surgical field grade, which was expressed in a NRS of 0-5 \[[@B11]\] ([Table 2](#T2){ref-type="table"}). The precise amount of blood loss could not be measured, but hemoglobin figures before and directly after surgery were measured to investigate the difference.

Statistical analysis was done with SPSS (version 18.0, SPSS Incorporation, Chicago, IL, USA). Each category was expressed in the form of the mean (SD), and comparison analysis was done with Student\'s t-test and Chi-square test. It was considered statistically significant when the P value was less than 0.05.

Results
=======

There were no statistical differences in the demographic characteristics or in the extent of sinusitis between the two groups ([Table 3](#T3){ref-type="table"}). There were also no statistical differences in the operating time, mean remifentanil infusion rate, amount of fluid administered during surgery, mean arterial pressure, and heart rate and in hemoglobin figures measured before and after surgery between the two groups ([Table 4](#T4){ref-type="table"}).

The NRS of the surgical field grade was lower in the PR group than in the DR group (2.3 \[0.57\] vs 2.7 \[0.67\], P = 0.006). Twenty-one patients in the PR group and seventeen patients in the DR group exhibited high-LM scores, while 15 in the PR group and 15 in the DR group exhibited low-LM scores. In the high-LM score, the surgical field grade, NRS, was lower in the PR group than in the DR group (2.4 \[0.67\] vs 3.0 \[0.63\], P = 0.012), but there were no statistical differences between the PR group and DR group in the low-LM score (2.4 \[0.56\] vs 2.2 \[0.42\], P = 0.861) ([Table 5](#T5){ref-type="table"}).

The NRS of the surgical field grade was significantly higher in the high-LM score patients than in the low-LM score patients in the DR group.

Discussion
==========

In the results of this study, the intravenous anesthesia group using propofol/remifentanil provided better visibility for the surgical field than the inhalation anesthesia group using desflurane/remifentanil. The visual status was especially good in the intravenous anesthesia group in the high-LM score patients.

Desflurane is a representative inhalation anesthesia that has been clinically used since it was first introduced in 1992. Desflurane produces two distinct cardiovascular actions \[[@B12]\]. First, desflurane decreases left ventricular systolic and diastolic function. It decreases systemic vascular resistance and mean arterial blood pressure in a dose-dependent fashion. Heart rate is unchanged at lower steady-state concentrations, but increases with higher concentrations. Second, when endtidal concentration rapidly increases to more than 1 minimum alveolar concentration, it accelerates the sympathetic nerve system to increase the heart rate and mean arterial pressure. In our study, these characteristics of desflurane were taken consideration, and the flow was controlled at 2 L/min to prevent a rapid increase in alveolar concentration.

Propofol is a representative intravenous anesthesia which causes a decrease in the mean arterial pressure by reducing cardiac output and systemic vascular resistance. However it has the characteristic where the heart rate increases according to the fall in blood pressure, which is slowed down due to the suppression of the baroreflex \[[@B13]\].

Remifentanil reduces the mean arterial pressure by reducing the cardiac output without reducing systemic vascular resistance; thus, it generally reduces capillary bleeding in ESS and improves visibility during surgery \[[@B14]\]. Inhalation anesthesia, intravenous anesthesia, and opioids all suppress the cardiovascular relationship to reduce the mean arterial pressure, but the mechanism in which the mean arterial pressure is reduced shows differences according to each drug. Inhalation anesthesia largely reduces the arterial pressure according to the reducing systemic vascular resistance; thus, despite low blood pressure, capillary bleeding increases \[[@B15]\]. Propofol also reduces the vascular resistance, but there is difference between inhalation agents to propofol. In contrast, propofol may either reset or inhibit the baroreflex, reducing the tachycardiac response to hypotension from decreased systemic vascular resistance \[[@B16]\]. In addition, when propofol is continually infused, it can cause a reduction in the cerebral perfusion pressure, which regulates the cerebral blood flow \[[@B17]\]. The ethmoid, sphenoid, frontal sinuses are supplied with blood by the branches of internal carotid artery: the ethmoidal and supraorbital artery \[[@B18]\]. The internal carotid artery is a division of cerebral circulation. Therefore, reduced bleeding can be expected due to the reduced blood flow around the paranasal sinuses.

As can be seen, when comparing inhalation anesthesia and intravenous anesthesia, there are differences in the mechanism by which the mean arterial pressure is reduced, and each drug has its own characteristics.

As a method to evaluate the extent of chronic sinusitis, there is the Lund-Mackay CT staging system. In contrast to other staging systems, the Lund-Mackay staging system introduces a point system instead of stages therefore, when other staging systems have around 4 stages, the Lund-Mackay can have up to 25 stages from 0 point to 24 points, which had the effect of being able to specify small differences in lesions. In addition, the points were simplified to 0 point (normal), 1 point (partially corrupt), and 2 points (completely corrupt), which heightened the concordance within observers and between observers. Lund and Mackay \[[@B10]\] reported that there was a 98% concordance between two observers in 200 cases, and emphasized the system\'s user friendliness through simplification. On the basis of the report that severity increases as LM score increases such as mild (0-6), moderate (7-12), moderately severe (13-18), and severe (19-24) \[[@B19]\], the LM score was categorized into low (0-12) and high (13-24). As the LM-score elevated, it means that the extent of sinusitis was severe and that there was increased vessel distribution in the operating area, which can be a predictive factor for the tendency of high bleeding \[[@B20]\]. Beule et al. \[[@B21]\] compared anesthesia using propofol and anesthesia using sevoflurane, and Yoo et al. \[[@B22]\] also compared anesthesia using propofol/remifentanil, anesthesia using sevoflurane/remifentanil, and anesthesia using desflurane/remifentanil, but these studies did not consider the difference of the LM score, and thus, the results were that there were no differences between the anesthetic drugs. Ahn et al. \[[@B9]\] compared ESS in patients who received inhalation anesthesia of sevoflurane/remifentanil and intravenous anesthesia of propofol/remifentanil, and reported that in low-LM scores, there was a similar visibility for the surgical field regardless of the anesthetic drug, but in high-LM score, there were significant differences according to the type of anesthesia used. Our study compared anesthesias using propofol/remifentanil and desflurane/remifentanil, and also compared the difference according to the LM score. Our study revealed that in the low-LM score, a similar level of visibility was obtained regardless of anesthetic drug, but in the high-LM score, anesthesia using propofol/remifentanil had a better visibility of the surgical field compared to the anesthesia using desflurane/remifentanil.

Aside from this, many other factors affect the degree of bleeding during ESS. Therefore, this study tried to control for the other factors that may affect bleeding to investigate the difference according to the anesthetic drug. The mean arterial pressure, which mainly contributes to bleeding during surgery, was maintained at 70-80 mmHg, the lowest constraint of blood pressure which does not cause ischemia in the organs, and the pulse rate per minute was maintained around 70 during the surgery. Additionally, to compensate for the limitation of the study deducing results from subjective NRS, a single surgeon evaluated the visibility of the surgical field.

To remove personal error from the evaluation of the visible surgical field, an important result in our study would be to measure the actual blood loss. The authors did measure the difference in hemoglobin figures before and after surgery instead of actual blood loss. However, it is hard to determine an accurate amount of blood loss with these figures due to the effect of fluids being administered during surgery and the short operating time resulting in an insufficient hemoglobin compensation time. Like the study by Ahn et al. \[[@B9]\], the study is limited in the fact that the actual blood loss was not evaluated along with the visible surgical field. In addition, further research regarding the difference in the visible surgical field according to anesthesia and LM score should be conducted in a 3-way research with desflurane and sevoflurane, as in a study by Yoo et al. \[[@B22]\].

This study revealed that in ESS, patients with a high-LM score had a better visible surgical field for the operating surgeon when under intravenous anesthesia using propofol/remifentanil than under inhalation anesthesia using desflurane/remifentanil. It should be considered that using propofol/remifentanil for general anesthesia will be helpful when performing ESS.

This work was supported by Grant from Inje University, 2010.

This is a thesis for a master\'s degree.

###### 

Lund-Mackay Computed Tomography Staging System

![](kjae-63-302-i001)

###### 

Surgical Grade Scoring System Designed Specifically for Use in Endoscopic Sinus Surgery
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Demographic and Clinical Characteristics of Patients
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The values are reported as the mean (SD) or the number of patients. Group DR: desflurane/remifentanil group, Group PR: propofol/remifentanil group, ASA: American Society of Anesthesiologists physical status, LM: Lund-Mackay, High LM score: LM score \> 12, Low LM score, LM score ≤ 12.
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Intraoperative Variables
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The values are reported as the mean (SD) or the number of patients. Group DR: desflurane/remifentanil group, Group PR: propofol/remifentanil group, MAP: mean arterial pressure, HR: heart rate, Difference of Hgb: the value taking out postoperative hemoglobin figure from preoperative hemoglobin figure.
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Numeric Rating Scale of Surgical Field Grade
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The values are reported as the mean (SD) or the number of patients. Group DR: desflurane/remifentanil group, Group PR: propofol/remifentanil group, LM: Lund-Mackay, High LM score: LM score \> 12, Low LM score: LM score ≤ 12. ^\*^P \< 0.05 compared to Group PR, ^†^P \< 0.05 compared to High LM of Group PR and Low LM of Group DR and PR.
